sodium selenite has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackermann, T; Blyth, K; Gottlieb, E; Kalna, G; Mackay, G; Nixon, C; Pfetzer, N; Sumpton, D; Tardito, S; Vande Voorde, J | 1 |
1 other study(ies) available for sodium selenite and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Improving the metabolic fidelity of cancer models with a physiological cell culture medium.
Topics: Arginine; Argininosuccinate Lyase; Cell Line, Tumor; Cell Proliferation; Culture Media; Female; Ferroptosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Models, Biological; Pyruvic Acid; Sodium Selenite; Spheroids, Cellular; Triple Negative Breast Neoplasms; Tumor Microenvironment; Urea | 2019 |